N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ketamine (Primary) ; Antidepressants
- Indications Major depressive disorder
- Focus Therapeutic Use
- 20 Apr 2017 Biomarkers information updated
- 09 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 27 Apr 2012 New trial record